Compugen Ltd
NASDAQ:CGEN
Compugen Ltd
NASDAQ:CGEN
Price:
1.74 USD
-17.54%
Updated:
May 21, 2024
Compugen Ltd
Net Issuance of Common Stock
|
Compugen Ltd
Net Issuance of Common Stock Peer Comparison
Comparables:
Q
QNRX
B
BOLT
Competitive Net Issuance of Common Stock Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Net Issuance of Common Stock | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Compugen Ltd
NASDAQ:CGEN
|
Net Issuance of Common Stock
$1.4m
|
CAGR 3-Years
-63%
|
CAGR 5-Years
-46%
|
CAGR 10-Years
-25%
|
|
Q
|
Quoin Pharmaceuticals Ltd
NASDAQ:QNRX
|
Net Issuance of Common Stock
$5.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-4%
|
CAGR 10-Years
N/A
|
|
B
|
Biolight Life Sciences Ltd
TASE:BOLT
|
Net Issuance of Common Stock
₪3.9m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-36%
|
CAGR 10-Years
-10%
|
See Also
What is Compugen Ltd's Net Issuance of Common Stock?
Net Issuance of Common Stock
1.4m
USD
1.4m
USD
Based on the financial report for Dec 31, 2023, Compugen Ltd's Net Issuance of Common Stock amounts to 1.4m USD.
What is Compugen Ltd's Net Issuance of Common Stock growth rate?
Net Issuance of Common Stock CAGR 10Y
-25%
-25%
Over the last year, the Net Issuance of Common Stock growth was 286%. The average annual Net Issuance of Common Stock growth rates for Compugen Ltd have been -63% over the past three years , -46% over the past five years , and -25% over the past ten years .
You don't have any saved screeners yet
